Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹7,133 Cr
up ₹7.5 Cr vs Mar 2024
- Stocks held
- 31
- unchanged
- Top 10 weight
- 58.3%
- of the portfolio in its ten largest
- Cash & debt
- 3.8%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 11
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In April 2024 it disclosed 31 stocks worth ₹7,133 Cr, up ₹7.5 Cr from Mar 2024. Its largest positions were Sun Pharmaceutical Industries Limited (13.8%), Lupin Limited (8.5%), Cipla Limited (6.1%); the ten largest together made up 58.3% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 79.0% of its equity. Cash and debt stood at 3.8%. Compared with Mar 2024 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
79%
Top-10 weight is higher than 79% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
57%
Holds more cash than 57% of peers
Holdings in April 2024
Download CSVEvery line the fund disclosed, with the change against Mar 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.81%
- Δ weight
- down 1.10 pts
- Value
- ₹985 Cr
- Δ value
- down ₹77.7 Cr
- Status
- Trimmed
- Weight
- 8.55%
- Δ weight
- up 0.14 pts
- Value
- ₹610 Cr
- Δ value
- up ₹10.8 Cr
- Status
- Added
- Weight
- 6.08%
- Δ weight
- down 0.43 pts
- Value
- ₹434 Cr
- Δ value
- down ₹30.1 Cr
- Status
- Trimmed
- Weight
- 5.41%
- Δ weight
- down 0.38 pts
- Value
- ₹386 Cr
- Δ value
- down ₹26.6 Cr
- Status
- Trimmed
- Weight
- 5.05%
- Δ weight
- up 0.70 pts
- Value
- ₹361 Cr
- Δ value
- up ₹50.2 Cr
- Status
- Added
- Weight
- 4.78%
- Δ weight
- up 0.03 pts
- Value
- ₹341 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
- Weight
- 4.08%
- Δ weight
- down 0.32 pts
- Value
- ₹291 Cr
- Δ value
- down ₹22.8 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 3.84%
- Δ weight
- up 2.41 pts
- Value
- ₹274 Cr
- Δ value
- up ₹172 Cr
- Status
- Added
- Weight
- 3.70%
- Δ weight
- up 0.26 pts
- Value
- ₹264 Cr
- Δ value
- up ₹18.8 Cr
- Status
- Added
- Weight
- 3.61%
- Δ weight
- down 0.57 pts
- Value
- ₹258 Cr
- Δ value
- down ₹40 Cr
- Status
- Trimmed
- Weight
- 3.20%
- Δ weight
- down 0.09 pts
- Value
- ₹228 Cr
- Δ value
- down ₹5.8 Cr
- Status
- Trimmed
- Weight
- 3.10%
- Δ weight
- up 0.28 pts
- Value
- ₹221 Cr
- Δ value
- up ₹19.8 Cr
- Status
- Added
- Weight
- 3.01%
- Δ weight
- down 0.02 pts
- Value
- ₹215 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 3.01%
- Δ weight
- up 0.04 pts
- Value
- ₹214 Cr
- Δ value
- up ₹2.8 Cr
- Status
- Added
- Weight
- 2.99%
- Δ weight
- up 0.08 pts
- Value
- ₹213 Cr
- Δ value
- up ₹5.7 Cr
- Status
- Added
- Weight
- 2.91%
- Δ weight
- up 0.16 pts
- Value
- ₹208 Cr
- Δ value
- up ₹11.7 Cr
- Status
- Added
- Weight
- 2.75%
- Δ weight
- up 0.07 pts
- Value
- ₹196 Cr
- Δ value
- up ₹5 Cr
- Status
- Added
- Weight
- 2.71%
- Δ weight
- up <0.01 pts
- Value
- ₹193 Cr
- Δ value
- up ₹50 L
- Status
- Held
- Weight
- 2.56%
- Δ weight
- down 0.06 pts
- Value
- ₹182 Cr
- Δ value
- down ₹4.1 Cr
- Status
- Trimmed
- Weight
- 2.50%
- Δ weight
- up 0.17 pts
- Value
- ₹178 Cr
- Δ value
- up ₹12 Cr
- Status
- Added
- Weight
- 2.24%
- Δ weight
- up 0.03 pts
- Value
- ₹159 Cr
- Δ value
- up ₹2.5 Cr
- Status
- Added
- Weight
- 1.90%
- Δ weight
- up 0.03 pts
- Value
- ₹135 Cr
- Δ value
- up ₹2 Cr
- Status
- Added
- Weight
- 1.72%
- Δ weight
- up 0.07 pts
- Value
- ₹123 Cr
- Δ value
- up ₹5.1 Cr
- Status
- Added
- Weight
- 1.60%
- Δ weight
- up 0.13 pts
- Value
- ₹114 Cr
- Δ value
- up ₹9.7 Cr
- Status
- Added
- Weight
- 1.09%
- Δ weight
- up 0.03 pts
- Value
- ₹78 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 1.09%
- Δ weight
- down 0.02 pts
- Value
- ₹77.5 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 0.84%
- Δ weight
- down 0.01 pts
- Value
- ₹60 Cr
- Δ value
- down ₹31 L
- Status
- Trimmed
- Weight
- 0.59%
- Δ weight
- up 0.05 pts
- Value
- ₹41.9 Cr
- Δ value
- up ₹3.7 Cr
- Status
- Added
- Weight
- 0.53%
- Δ weight
- up 0.03 pts
- Value
- ₹38 Cr
- Δ value
- up ₹2 Cr
- Status
- Added
- Weight
- 0.48%
- Δ weight
- up <0.01 pts
- Value
- ₹34.2 Cr
- Δ value
- up ₹4 L
- Status
- Held
- Weight
- 0.21%
- Δ weight
- up 0.02 pts
- Value
- ₹14.7 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 0.07%
- Δ weight
- down 0.31 pts
- Value
- ₹4.7 Cr
- Δ value
- down ₹22.2 Cr
- Status
- Trimmed
What changed, Mar 2024 to Apr 2024
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Divi's Laboratories Limitedup ₹50.2 Cr (+0.70% pts)
- Vijaya Diagnostic Centre Limitedup ₹19.8 Cr (+0.28% pts)
- JB Chemicals & Pharmaceuticals Limitedup ₹18.8 Cr (+0.26% pts)
- GlaxoSmithKline Pharmaceuticals Limitedup ₹12 Cr (+0.17% pts)
- Aurobindo Pharma Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2024, the weight rose most in Healthcare Services (+0.3 pts), and fell most in Pharmaceuticals & Biotechnology (−0.4 pts).
- Healthcare Services16.7% → 17.0%+0.3 pts
- Pharmaceuticals & Biotechnology79.4% → 79.0%−0.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2021 | Apr 2023 | Oct 2023 | Jan 2024 | Mar 2024 | Apr 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 80.6% | 77.7% | 77.2% | 77.4% | 79.4% | 79.0% |
| Healthcare Services | 16.4% | 18.5% | 17.0% | 18.2% | 16.7% | 17.0% |
| Retailing | — | 2.1% | 4.6% | 3.2% | 3.1% | 3.1% |
| Pharmaceuticals | 2.3% | 1.4% | 1.1% | 1.0% | 0.9% | 0.9% |
Allocation in Apr 2024change vs Mar 2024
- Pharmaceuticals & Biotechnology (21)79.0%▼ 0.4 pts
- Healthcare Services (8)17.0%▲ 0.3 pts
- Retailing (1)3.1%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Apr 2024
3.8%
▲ 2.4 pts vs Mar 2024
- Cash alone
- 3.8%
- cash and net receivables
- A year earlier
- 3.2%
- Apr 2023 · now ▲ 0.6 pts
- Last 12 months
- 0.5% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.